Prescribing habits in primary biliary cirrhosis: A national survey

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 8, 1999, Pages 817-820

  Verma, Ashwin ^a   Jazrawi, Riadh P ^a   Ahmed, Hafez A ^a   Northfield, Timothy C ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Drugs; PBC; Prescription; Questionnaire

Indexed keywords

ANTIHISTAMINIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLCHICINE; COLESTYRAMINE; IMMUNOSUPPRESSIVE AGENT; PENICILLAMINE; RIFAMPICIN; STEROID; URSODEOXYCHOLIC ACID; VITAMIN;

ARTICLE; GASTROENTEROLOGY; HORMONE SUBSTITUTION; MEDICAL PRACTICE; OSTEOPOROSIS; PRESCRIPTION; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM;

EID: 0032812568     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199908000-00001     Document Type: Article

References (34)

1. 1 Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335:1570-1580.
2. 2 Lombard M, Portmann B, Neuberger J, Williams R, Tygstrup N, Ranek L, et al. Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology 1993; 104:519-526.
3. 3 Poupon RE, Balkau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991; 324:1548-1554.
4. 4 Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blondis LM, Ghent CN, et al. The Canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994; 19:1149-1156.
5. 5 Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994; 106:1284-1290.
6. 6 Matloff DS, Alpert E, Resnick RH, Kaplan MM. A prospective trial of D-penicillamine in primary biliary cirrhosis. N Engl J Med 1982; 306:319-326.
7. 7 Kaplan MM, Alling DW, Zimmerman HJ, Wolfe HJ, Sepersky RA, Hirsch GS, et al. A prospective trial of colchicine for primary biliary cirrhosis. N Engl J Med 1986; 315:1448-1454.
8. 8 Combes B, Carithers RL, Maddrey WC, Lin D, McDonald MF, Wheeler DE, et al. A randomised, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995; 22:759-766.
9. 9 Poupon RE, Poupon R, Balkau B. Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. N Engl J Med 1994; 330:1342-1347.
10. 10 Lindor KD, Therneau TM, Jorgensen RA, Malinchoc M, Dickson ER. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology 1996; 110:1515-1518.
11. 11 Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology 1997; 113:884-890.
12. 12 Triger DR. Primary biliary cirrhosis: an epidemiological study. BMJ 1980; 281:772-775.
13. 13 Hislop WS. Primary biliary cirrhosis: an epidemiological study. BMJ 1980; 281:1069-1070.
14. 14 Hislop WS, Main G, Robertson AJS. Primary biliary cirrhosis: experience of a non-referral centre. Lancet 1981; ii:144.
15. 15 Metcalf J, Bhopal R, Howell J, Myszor M, James OFW. PBC: increased incidence and prevalence together with geographical variation in one UK region [Abstract]. Gut 1998; 42(suppl 1):A31.
16. 16 Podda M, Ghezzi C, Battezzati PM, Bertolini E, Crosignani A, Petroni ML, et al. Effect of different doses of ursodeoxycholic acid in chronic liver disease. Dig Dis Sci 1989; 34:59S-65S.
17. 17 Wiesner RH, Ludwig J, Lindor KD, Jorgensen RA, Baldus WP, Homburger HA, et al. A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med 1990; 322:1419-1424.
18. 18 Sharma A, Provenzale D, McKusick A, Kaplan MM. Interstitial pneumonitis after low-dose methotrexate therapy in primary biliary cirrhosis. Gastroenterology 1994; 107:266-270.
19. 19 Stellon AJ, Davies A, Compston J, Williams R. Osteoporosis in chronic liver disease. Q J Med 1985; 57:783-790.
20. 20 Dickson ER, Fleming TR, Wiesner RH, Baldus WP, Fleming CR, Ludwig J, et al. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985; 312:1011-1015.
21. 21 Neuberger J, Christensen E, Portmann B, Caballeria J, Rodes J, Ranek L, et al. Double blind controlled trial of D-penicillamine in patients with primary biliary cirrhosis. Gut 1985; 26:114-119.
22. 22 Ebstein O, Jain S, Lee RG, Cook DG, Boss AM, Scheuer PJ, et al. D-penicillamine treatment improves survival in primary biliary cirrhosis. Cancel 1981; ii:1275-1277.
23. 23 Vuoristo M, Farkkila M, Karvonen A, Leino R, Lehtola J, Makinen J, et al. A placebo controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid. Gastroenterology 1995; 108:1470-1478.
24. 24 Lim AG, Wolfhagen HJ, Verma A, Van Buuren HR, Jazrawi RP, Levy JH, et al. Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: effect of ursodeoxycholic acid and immunosuppressive therapy. Eur J Gastroenterol Hepatol 1997; 9:155-161.
25. 25 Ikeda T, Tozuka S, Noguchi O, Kobayashi F, Sakamoto S, Marumo FS, et al. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study. J Hepatol 1996; 24:88-94.
26. 26 Leuschner M, Guldutuna S, You T, Hubner K, Bhatti S, Leuschner U. Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. J Hepatol 1996; 25:49-57.
27. 27 Wolfhagen FH, Van Buuren HR, Schalm SW. Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis. Neth J Med 1994; 44:84-90.
28. 28 Gonzalez-Koch A, Brahm J, Antezana C, Smok G, Cumsille MA. The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone. J Hepatol 1997; 27:143-149.
29. 29 Lindor KD, Dickson ER, Jorgensen RA, Anderson ML, Wiesner RH, Gores GJ, et al. The combination of ursodeoxycholic acid and methotrexate for patients with primary biliary cirrhosis: the results of a pilot study. Hepatology 1995; 22:1158-1162.
30. 30 Ghent CM, Carruthers SG. Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology 1988; 94:488-493.
31. 31 Wolfhagen FHJ, Sternieri E, Hop WCJ, Vitale G, Bertolotti M, Van Buuren HR. Oral naltrexone treatment for cholestatic pruritus: a double-blind, placebo-controlled study. Gastroenterology 1997; 113:1264-1269.
32. 32 Battezzati PM, Podda M, Bianchi FB, Naccarato R, Orlandi F, Surrenti C, et al. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. J Hepatol 1993; 17:332-338.
33. 33 Kaplan MM, Elta GH, Furie B, Sadowski JA, Russell RM. Fat-soluble vitamin nutriture in primary biliary cirrhosis. Gastroenterology 1988; 95:787-792.
34. 34 Stellon AJ, Webb A, Compston J, Williams R. Lack of osteomalacia in chronic cholestatic liver disease. Bone 1986; 7:181-185.